Navigation Links
The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments
Date:11/16/2010

BURLINGTON, Mass., Nov. 16, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to the launch of several novel agents, the hepatitis C virus (HCV) drug market will more than triple from approximately $2 billion in 2009 to nearly $7.5 billion in 2014 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Thereafter, the market will substantially decrease to $4.6 billion in 2019 due to decreasing prevalence of the disease and the high efficacy of new treatment regimens.

The Pharmacor 2010 findings from the topic entitled Hepatitis C Virus reveal that the standard of care for the indication will change significantly with the introduction of new classes of HCV-specific antiviral agents, such as protease inhibitors and polymerase inhibitors. Compounds from these new classes will initially be added to the backbone of currently used agents, forming triple or quadruple treatment regimens that are expected to be more efficacious than the current standard of care -- peg-IFN/ribavirin.

"Although complete elimination of peg-IFNs and ribavirin agents is highly desirable owing to their side effects, this change is unlikely to occur over the next decade," said Decision Resources Analyst Alexandra Makarova, M.D., Ph.D. "However, decreased treatment durations resulting from the addition of new antivirals could increase the tolerability of treatment regimens. The launch of novel HCV-specific agents will increase the size of the drug-treated population, owing mainly to re-treatment of prior non-responders as well as increased referral and drug-treatment rates."

The current standard of care for HCV -- often a nearly year-long treatment -- cures only about half of patients and is associated with severe side effects. Although the incidence of HCV has declined dramatically after the introduction of prevention measures such as b
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Abbott and Enanta Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C
2. AASLD Presidents Choice Lecture: The National Strategy for the Control of Viral Hepatitis and Liver Cancer
3. Telbivudine Given to Mothers With Hepatitis B Reduces Infection Rate in Infants
4. Achieving Sustained Viral Response for Patients with Recurrent Hepatitis C After Transplantation is Key for Long-Term Outcomes
5. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
6. Roche Receives FDA Approval for a Second-Generation Hepatitis C Viral Load Test
7. Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
8. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
9. Millions of Americans Are Living With Hidden Epidemics of Hepatitis B and C, Top Experts Warn
10. Launch of Novel Agents for the Treatment of Hepatitis C Virus Will Precipitate Treatment of At Least Half of Warehoused Patients
11. Roche Receives FDA Approval for Second-Generation Hepatitis B Viral Load Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 2014 Statistics released from a number of ... astronomically during the holidays, beginning with Thanksgiving eve, which ... The data, highlighted in an Infographic ... part of their annual Sober Days for the ... high-risk drinking and increased rates of DUI injuries and ...
(Date:11/22/2014)... , Nov. 21, 2014 Many power ... the growing influence of patients in the biopharmaceutical ... interactions. Now, more than ever, understanding how to ... medical products is essential. According ... LLC, benchmarked companies spent about two-thirds of their ...
(Date:11/21/2014)... , Nov. 21, 2014  Tandem Diabetes ... ), a medical device company and manufacturer of ... a partnership with Tidepool, a non-profit dedicated to ... source software platform that increases diabetes data accessibility. ... Platform, which is currently under development, to download ...
Breaking Medicine Technology:Alarming Stats Show Holiday Drinking an Issue for Many 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3
... July 20, 2011 One of Frantz Medical Group,s ... it has been awarded an Ohio Third Frontier grant ... system for penetrating through vascular Chronic Total Occlusions (CTOs), ... Coronary Artery Bypass Graft (CABG).   VasoStar,s ...
... VEGAS, July 20, 2011 Cardinal Health today announced ... national trade show for independent pharmacies, is the largest ... attendees. This year,s event, taking place ... Palazzo resort hotel, features a 100,000-square-foot trade show floor, ...
Cached Medicine Technology:Frantz Medical Group Subsidiary, VasoStar, Awarded $1 Million Research Grant 2Frantz Medical Group Subsidiary, VasoStar, Awarded $1 Million Research Grant 3Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 2Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 3Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 4
(Date:11/23/2014)... (HealthDay News) -- The holidays can be a challenge ... can trigger major meltdowns, an expert says. "Holidays ... circumstances, but when you have children with special needs, ... therapy professor at University of the Sciences in Philadelphia, ... to let your hosts or visitors know what special ...
(Date:11/23/2014)... More than two dozen new claims were ... involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), as well as ... , A Case List updated on November 17th ... 2 diabetes medications referred to as incretin mimetics have ... District of California, where a federal proceeding continues to ...
(Date:11/23/2014)... (PRWEB) November 23, 2014 Syngenta lawsuits ... on behalf of farmers and agribusinesses that have allegedly ... to commercialize Agrisure Viptera and Agrisure Duracade, genetically ... been approved for sale in China. According to a ... to virtually ban U.S. corn imports. Because China is ...
(Date:11/22/2014)... 23, 2014 A new AlignLife Chiropractic ... in the downtown Greenville area. Dr. Chelsea Sineath, owner ... decided to open her own clinic after working in ... the patients. , AlignLife believes that the body ... a focus on chiropractic care and rehabilitation to allow ...
(Date:11/22/2014)... Recently, Locks-Magnetic.com , one of ... promotion of mag locks for glass doors online. In ... on these fresh products. Customers can get more information ... doors are in excellent performance. Customers who want to ... soon as possible. They also can enjoy the ...
Breaking Medicine News(10 mins):Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2Health News:Discounted Mag Locks for Glass Doors Revealed by Locks-Magnetic.com 2
... ... Therapy of Cancer (iSBTc), the U.S. Food and Drug Administration approval of Dendreon,s ... advance in the development of biological therapy (also called immunotherapy) for cancer treatment. ... as active cellular immunotherapies. , ...
... A team of researchers at the University of Georgia ... five years from the National Institutes of Health to study ... drug abuse relapse. "Drug abuse is closely linked ... treating addiction is preventing the relapse caused by stress," said ...
... ... alcohol regulations to keep them safe, according to a new poll conducted by a bipartisan ... showed that 75% of adults support “the rights of individual states to set their own ... ...
... approach lengthens survival, to varying degrees, for men with ... News) -- The U.S. Food and Drug Administration ... aimed at preventing the spread of prostate cancer in ... The new approval is limited to "the treatment of ...
... equal opportunity destroyer. It attacks the central nervous system ... victims are celebrated cellist Jacqueline du Pre, whose career was ... writers but they are far from alone. ... about 400,000 cases in the U.S. and more that 2 ...
... care, economic equality as reasons why , THURSDAY, April ... than Americans, likely due to the United States, lack ... and economic equality, a new study suggests. , U.S. ... of Health 2002-03 and found that Canadians can expect ...
Cached Medicine News:Health News:FDA Approval of new Prostate Treatment Shows Promise of Cancer Immunotherapy 2Health News:FDA Approval of new Prostate Treatment Shows Promise of Cancer Immunotherapy 3Health News:UGA, Emory to study how exercise may prevent drug abuse relapse 2Health News:Survey Finds Broad Support for Alcohol Regulations to Keep the Public Safe 2Health News:Prostate Cancer Vaccine Gains FDA Approval 2Health News:Prostate Cancer Vaccine Gains FDA Approval 3Health News:Catching multiple sclerosis before it strikes 2Health News:Catching multiple sclerosis before it strikes 3Health News:Canadians Leading Longer, Healthier Lives Than Americans 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: